Wir sind mit live! Mehr erfahren

INNOVATE Corp

VATE

Börsenwert 81,9 Mio. $

6,00 USD

-0,21

3,38 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

1 Tag

-3,38 %

5 Tage

-15,37 %

1 Monat

-20 %

3 Monate

-35,83 %

6 Monate

-44,24 %

Seit Jahresbeginn

15,38 %

1 Jahr

33,33 %

5 Jahre

-83,87 %

10 Jahre

-88,3 %

Profil: Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.

Mitarbeiter: 3.738

Industrie Ingenieur- und Bauwesen

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 20 %

Neutral 70 %

Negativ 10 %

Zacks Investment Research

INNOVATE Completes DBM Global Sale, Targets Debt Reduction

VATE completes the DBM Global sale for about $413 million in cash plus IES shares, with net proceeds earmarked to reduce debt and boost flexibility.

INNOVATE Completes DBM Global Sale, Targets Debt Reduction

INNOVATE Completes Sale of DBM Global to IES Holdings

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that it has completed the previously announced sale of DBM Global, Inc. (“DBMG”) to IES Holdings, Inc. (Nasdaq: IESC) (“IES”) pursuant to the Transaction Agreement (the “Agreement”) announced on August 10, 2026 (the “Transaction”).

INNOVATE Completes Sale of DBM Global to IES Holdings

INNOVATE Announces Closing of the Sale of a Controlling Interest in its Broadcasting Segment to CONX

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.

INNOVATE Announces Closing of the Sale of a Controlling Interest in its Broadcasting Segment to CONX

Zacks Investment Research

VATE Q2 Earnings Improve Y/Y as Infrastructure Revenues Surge

INNOVATE swings to a Q2 profit as revenues surge 74.2% y/y, fueled by DBM Global's growth, wider margins and backlog gains, while debt and liquidity remain in focus.

VATE Q2 Earnings Improve Y/Y as Infrastructure Revenues Surge

MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology

NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, and an equity method investment of INNOVATE, announced that The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, has nominated the MediBeacon® TGFR™ System for the 2026 Prix Galien USA Best Medical Technology.

MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology

IES Holdings to Acquire DBM Global

HOUSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- IES Holdings, Inc. (“IES”) (NASDAQ: IESC) today announced that it has entered into a definitive agreement to acquire DBM Global Inc. (“DBM Global”), a vertically integrated structural steel fabrication, erection and industrial services platform, from INNOVATE Corp. (“INNOVATE”) (NYSE: VATE) (the “Transaction”). The consideration for DBM Global, including minority interests, is approximately $650 million, comprised of cash and shares of IES common stock.

IES Holdings to Acquire DBM Global

INNOVATE Agrees to $650 Million Sale of DBM Global to IES Holdings

NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that it has entered into a Transaction Agreement (the “Agreement”) pursuant to which IES Holdings, Inc. (Nasdaq: IESC) (“IES”) will acquire DBM Global, Inc. (“DBMG”) for cash and stock consideration valued at $650 million (the “Transaction”).

INNOVATE Agrees to $650 Million Sale of DBM Global to IES Holdings

INNOVATE Q2 Earnings Call Highlights

INNOVATE NYSE: VATE reported second-quarter 2026 revenue of $421.6 million, up 74.2% from $242 million a year earlier, as its Infrastructure segment delivered record revenue, wider margins and backlog growth. The company posted net income attributable to common and participating preferred stockholders of $10.4 million, or $0.71 per fully diluted share, compared with a net loss of $22 million, or $1.67 per fully diluted share, in the prior-year quarter.

INNOVATE Q2 Earnings Call Highlights

INNOVATE Corp. (VATE) Q2 2026 Earnings Call Prepared Remarks Transcript

INNOVATE Corp. (VATE) Q2 2026 Earnings Call Prepared Remarks Transcript

INNOVATE Corp. (VATE) Q2 2026 Earnings Call Prepared Remarks Transcript

INNOVATE Corp. to Report Second Quarter 2026 Results on August 6th

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the second quarter 2026 on Thursday, August 6, 2026, after market close.

INNOVATE Corp. to Report Second Quarter 2026 Results on August 6th

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt